15548-45-5Relevant articles and documents
Glycosylation in room temperature ionic liquid using unprotected and unactivated donors
Park, Tae-Joon,Weiwer, Michel,Yuan, Xuejun,Baytas, Sultan N.,Munoz, Eva M.,Murugesan, Saravanababu,Linhardt, Robert J.
, p. 614 - 620 (2007)
Glycosylation in room temperature ionic liquid is demonstrated using unprotected and unactivated donors. Modest yields of simple benzyl glycosides and disaccharides of glucose, mannose and N-acetylgalactosamine were obtained in 1-ethyl-3-methylimidazolium benzoate with Amberlite IR-120 (H+) resin or p-toluenesulfonic acid as promoters.
Rhamnogalacturonan II: Chemical Synthesis of a Substructure Including α-2,3-Linked Kdo**
Mancuso, Enzo,Romanò, Cecilia,Trattnig, Nino,Gritsch, Philipp,Kosma, Paul,Clausen, Mads H.
supporting information, p. 7099 - 7102 (2021/04/19)
The synthesis of a fully deprotected Kdo-containing rhamnogalacturonan II pentasaccharide is described. The strategy relies on the preparation of a suitably protected homogalacturonan tetrasaccharide backbone, through a post-glycosylation oxidation approach, and its stereoselective glycosylation with a Kdo fluoride donor.
INHIBITORS OF HEXOKINASE AND METHODS OF USE THEREOF
-
Page/Page column 77; 78, (2018/09/25)
Provided herein are substituted substituted heterocycles useful as inhibitors of the HKII enzyme. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention further provides medical uses of substituted heterocycles, for example, as antitumor agents.
